Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6219)
All Articles published online
|
Jan 14, 2013 (publication date) through Jan 28, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hosokawa T, Kurosaki M, Tsuchiya K, Matsuda S, Muraoka M, Suzuki Y, Tamaki N, Yasui Y, Nakata T, Nishimura T, Suzuki S, Ueda K, Nakanishi H, Itakura J, Takahashi Y, Izumi N. Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy. World J Gastroenterol 2013; 19(2): 249-257 [PMID: 23345948 DOI: 10.3748/wjg.v19.i2.249] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i2/249.htm |
| Number | Citing Articles |
| 1 |
Huimin Yin, Zhanjie Yan, Fangcheng Zhao. Risk factors of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: Systematic review and meta-analysis. Technology and Health Care 2024; 32(6): 3943 doi: 10.3233/THC-231331
|
| 2 |
Guanghua Liu, Fang Xia, Guoping Fan, Juming Yu, Lei Bao, Caiyuan Zhang, Runmin Chi, Tingting Zhang, Lijun Wang, Feng Shen, Dengbin Wang. Type 2 diabetes mellitus worsens the prognosis of intermediate-stage hepatocellular carcinoma after transarterial chemoembolization. Diabetes Research and Clinical Practice 2020; 169: 108375 doi: 10.1016/j.diabres.2020.108375
|
| 3 |
Thanida Tangjarusritaratorn, Watip Tangjittipokin, Tada Kunavisarut. Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 1563 doi: 10.2147/DMSO.S295753
|
| 4 |
Charupong Saengboonmee, Wunchana Seubwai, Chawalit Pairojkul, Sopit Wongkham. High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation. Scientific Reports 2016; 6(1) doi: 10.1038/srep18995
|
| 5 |
Wei-Ru Cho, Chih-Chi Wang, Meng-Yun Tsai, Chen-Kai Chou, Yueh-Wei Liu, Yi-Ju Wu, Ming-Tsung Lin, Kuang-Den Chen, Ching-Hui Chuang, Pao-Yuan Huang, Tsung-Hui Hu, Ming-Chao Tsai, Ming-Lung Yu. Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patients. PLOS ONE 2021; 16(3): e0247231 doi: 10.1371/journal.pone.0247231
|
| 6 |
Lung‐Yi Mak, Rex Wan‐Hin Hui, Chi‐Ho Lee, XianHua Mao, Ka‐Shing Cheung, Danny Ka‐Ho Wong, David Tak‐Wai Lui, James Fung, Man‐Fung Yuen, Wai‐Kay Seto. Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes. Hepatology 2023; 77(2): 606 doi: 10.1002/hep.32716
|
| 7 |
Nalinie Joharatnam‐Hogan, Pinkie Chambers, Ketan Dhatariya, Ruth Board. A guideline for the outpatient management of glycaemic control in people with cancer. Diabetic Medicine 2022; 39(1) doi: 10.1111/dme.14636
|
| 8 |
Tae Young Ryu, Jiyoung Park, Philipp E. Scherer. Hyperglycemia as a Risk Factor for Cancer Progression. Diabetes & Metabolism Journal 2014; 38(5): 330 doi: 10.4093/dmj.2014.38.5.330
|
| 9 |
Teresa M. Salgado, Rotana M. Radwan, Erin Hickey Zacholski, Emily Mackler, Tonya M. Buffington, Kerri T. Musselman, William J. Irvin, Jennifer M. Perkins, Trang N. Le, Dave L. Dixon, Karen B. Farris, Vanessa B. Sheppard, Resa M. Jones. Oncologists’ responsibility, comfort, and knowledge managing hyperglycemia in patients with cancer undergoing chemotherapy: a cross sectional study. Supportive Care in Cancer 2023; 31(8) doi: 10.1007/s00520-023-07927-9
|
| 10 |
Hayato Baba, Makoto Kurano, Takeshi Nishida, Hideki Hatta, Ryoji Hokao, Koichi Tsuneyama. Facilitatory effect of insulin treatment on hepatocellular carcinoma development in diabetes. BMC Research Notes 2017; 10(1) doi: 10.1186/s13104-017-2783-6
|
| 11 |
Marin E. Healy, Sujoy Lahiri, Stefan R. Hargett, Jenny D.Y. Chow, Frances L. Byrne, David S. Breen, Brandon M. Kenwood, Evan P. Taddeo, Carolin Lackner, Stephen H. Caldwell, Kyle L. Hoehn. Dietary sugar intake increases liver tumor incidence in female mice. Scientific Reports 2016; 6(1) doi: 10.1038/srep22292
|
| 12 |
Xian-Fu Sun, Ying-Bo Shao, Ming-Ge Liu, Qi Chen, Zhao-Jun Liu, Bin Xu, Su-Xia Luo, Hui Liu. High-concentration glucose enhances invasion in invasive ductal breast carcinoma by promoting Glut1/MMP2/MMP9 axis expression. Oncology Letters 2017; 13(5): 2989 doi: 10.3892/ol.2017.5843
|
| 13 |
Juan Laguna, Marta Alegret, Núria Roglans. Simple Sugar Intake and Hepatocellular Carcinoma: Epidemiological and Mechanistic Insight. Nutrients 2014; 6(12): 5933 doi: 10.3390/nu6125933
|
| 14 |
R. Barua, A.J. Templeton, B. Seruga, A. Ocana, E. Amir, J.-L. Ethier. Hyperglycaemia and Survival in Solid Tumours: A Systematic Review and Meta-analysis. Clinical Oncology 2018; 30(4): 215 doi: 10.1016/j.clon.2018.01.003
|
| 15 |
Hande Topel, Ezgi Bağırsakçı, Yeliz Yılmaz, Ayşim Güneş, Gülsün Bağcı, Dehan Çömez, Erkan Kahraman, Peyda Korhan, Neşe Atabey. High glucose induced c-Met activation promotes aggressive phenotype and regulates expression of glucose metabolism genes in HCC cells. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-89765-5
|
| 16 |
Yongxia Qiao, Xiao Zhang, Yue Zhang, Yulan Wang, Yanfeng Xu, Xiangfan Liu, Fenyong Sun, Jiayi Wang. High Glucose Stimulates Tumorigenesis in Hepatocellular Carcinoma Cells Through AGER-Dependent O-GlcNAcylation of c-Jun. Diabetes 2016; 65(3): 619 doi: 10.2337/db15-1057
|
| 17 |
Su Youn Nam, Jihyeon Jeong, Won Kee Lee, Seong Woo Jeon. Sex-specific effect of body mass index and fasting glucose on gastric cancer risk and all causes mortality; a cohort study of 5.17 million. International Journal of Obesity 2022; 46(9): 1644 doi: 10.1038/s41366-022-01161-9
|
| 18 |
Katarina Popovic, Brigita Smolović, Milica Martinović, Ljiljana Vučković. The Relationship between Diabetes Mellitus and Pancreatic Cancer—Diabetes Mellitus as a Red Flag for Pancreatic Cancer. Cancer Epidemiology, Biomarkers & Prevention 2023; 32(3): 298 doi: 10.1158/1055-9965.EPI-22-0951
|
| 19 |
M Zhou, M T S Mok, H Sun, A W Chan, Y Huang, A S L Cheng, G Xu. The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP–PKA–EGFR–STAT3 axis. Oncogene 2017; 36(29): 4135 doi: 10.1038/onc.2017.38
|
| 20 |
Mathias Jachs, Hans L. Tillmann. It's not all about the virus—On the importance of modifiable lifestyle factors in the development of hepatocellular carcinoma in chronic hepatitis B. Hepatology 2023; 77(2): 352 doi: 10.1002/hep.32798
|
| 21 |
Yujian Zheng, Qing Cai, Lishan Peng, Shibo Sun, Shaoping Wang, Jie Zhou. Related Factors of Hepatocellular Carcinoma Recurrence Associated With Hyperglycemia After Liver Transplantation. Transplantation Proceedings 2021; 53(1): 177 doi: 10.1016/j.transproceed.2020.10.027
|
| 22 |
Chin-Wen Kuo, Hsiang-Ling Wu, Chun-Cheng Li, Juan P. Cata, Hsin-Yi Liu, Ming-Chih Hou, Yih-Giun Cherng, Ying-Hsuan Tai. Long-Term Survival Impact of High-Grade Complications after Liver Resection for Hepatocellular Carcinoma: A Retrospective Single-Centre Cohort Study. Medicina 2022; 58(4): 534 doi: 10.3390/medicina58040534
|
| 23 |
Chihiro Dohi, Kazuhiro Nouso, Koji Miyahara, Yuki Morimoto, Nozomu Wada, Hideaki Kinugasa, Yasuto Takeuchi, Kenji Kuwaki, Hideki Onishi, Fusao Ikeda, Shinichiro Nakamura, Hidenori Shiraha, Akinobu Takaki, Hiroyuki Okada. Potential of alpha‐fetoprotein as a prognostic marker after curative radiofrequency ablation of hepatocellular carcinoma. Hepatology Research 2016; 46(9): 916 doi: 10.1111/hepr.12636
|
| 24 |
Claudio Fiorillo, Giuseppe Quero, Vito Laterza, Pietro Mascagni, Fabio Longo, Roberta Menghi, Francesco Razionale, Fausto Rosa, Teresa Mezza, Ivo Boskoski, Andrea Giaccari, Sergio Alfieri. Postoperative hyperglycemia affects survival after gastrectomy for cancer: A single-center analysis using propensity score matching. Surgery 2020; 167(5): 815 doi: 10.1016/j.surg.2019.11.006
|
| 25 |
Teresa M. Salgado, Poorva B. Birari, Mona Alshahawey, Erin Hickey Zacholski, Emily Mackler, Tonya M. Buffington, Kerri T. Musselman, William J. Irvin, Jennifer M. Perkins, Trang N. Le, Dave L. Dixon, Karen B. Farris, Vanessa B. Sheppard, Resa M. Jones. Optimal hyperglycemia thresholds in patients undergoing chemotherapy: a cross sectional study of oncologists’ practices. Supportive Care in Cancer 2024; 32(8) doi: 10.1007/s00520-024-08756-0
|
| 26 |
Kazuto Tajiri, Hayato Baba, Kengo Kawai, Masami Minemura, Satoshi Yasumura, Terumi Takahara, Toshiro Sugiyama. Neutrophil‐to‐lymphocyte ratio predicts recurrence after radiofrequency ablation in hepatitis B virus infection. Journal of Gastroenterology and Hepatology 2016; 31(7): 1291 doi: 10.1111/jgh.13287
|
| 27 |
Victor M. Lu, Anshit Goyal, Lachlin S. Vaughan, Kerrie L. McDonald. The impact of hyperglycemia on survival in glioblastoma: A systematic review and meta-analysis. Clinical Neurology and Neurosurgery 2018; 170: 165 doi: 10.1016/j.clineuro.2018.05.020
|
| 28 |
Suangson Supabphol, Wunchana Seubwai, Sopit Wongkham, Charupong Saengboonmee. High glucose: an emerging association between diabetes mellitus and cancer progression. Journal of Molecular Medicine 2021; 99(9): 1175 doi: 10.1007/s00109-021-02096-w
|
| 29 |
Bhrigu Kumar Das, S.M. Choukimath, Pramod C. Gadad. Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieu. Life Sciences 2019; 230: 10 doi: 10.1016/j.lfs.2019.05.046
|
| 30 |
Marutpong Detarya, Salak Thaenkaew, Wunchana Seubwai, Somsiri Indramanee, Chatchai Phoomak, Charupong Saengboonmee, Sopit Wongkham, Chaisiri Wongkham. High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma. Life Sciences 2021; 271: 119114 doi: 10.1016/j.lfs.2021.119114
|
| 31 |
Toshiya Atsumi. Diabetes and risk of cancer. Diabetology International 2015; 6(3): 190 doi: 10.1007/s13340-015-0227-x
|
| 32 |
Surbhi Chouhan, Snahlata Singh, Dipti Athavale, Pranay Ramteke, Vimal Pandey, Jomon Joseph, Rajashekar Mohan, Praveen Kumar Shetty, Manoj Kumar Bhat. Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4. Scientific Reports 2016; 6(1) doi: 10.1038/srep27558
|
| 33 |
S. Uslu, N. Alaca, K. D. Kilic, A. Uysal, H. Kurtel. The effects of aerobic exercise frequencies on liver fibrosis, α-fetoprotein and cytokeratin 19 in experimental type 2 diabetes-induced rats: an immunohistochemistry study. Biotechnic & Histochemistry 2018; 93(8): 615 doi: 10.1080/10520295.2018.1517898
|
| 34 |
Jeong-Ju Yoo, Eun Ju Cho, Kyungdo Han, Soo Seong Heo, Bo-Yeon Kim, Dong Wook Shin, Su Jong Yu. Glucose Variability and Risk of Hepatocellular Carcinoma in Patients with Diabetes: A Nationwide Population-Based Study. Cancer Epidemiology, Biomarkers & Prevention 2021; 30(5): 974 doi: 10.1158/1055-9965.EPI-20-1654
|
| 35 |
Daryl Ramai, Waqqas Tai, Michelle Rivera, Antonio Facciorusso, Nicola Tartaglia, Mario Pacilli, Antonio Ambrosi, Christian Cotsoglou, Rodolfo Sacco. Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma. Biomedicines 2021; 9(2): 184 doi: 10.3390/biomedicines9020184
|
| 36 |
Charupong Saengboonmee, Chatchai Phoomak, Suangson Supabphol, Kyle R. Covington, Oliver Hampton, Chaisiri Wongkham, Richard A. Gibbs, Kazuo Umezawa, Wunchana Seubwai, Marie-Claude Gingras, Sopit Wongkham. NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cells. Life Sciences 2020; 262: 118548 doi: 10.1016/j.lfs.2020.118548
|
| 37 |
G. Ariaans, S. de Jong, J.A. Gietema, J.D. Lefrandt, E.G.E. de Vries, M. Jalving. Cancer-drug induced insulin resistance: Innocent bystander or unusual suspect. Cancer Treatment Reviews 2015; 41(4): 376 doi: 10.1016/j.ctrv.2015.02.007
|
| 38 |
Úna C. McMenamin, Stephen McCain, Andrew T. Kunzmann. Do smoking and alcohol behaviours influence GI cancer survival?. Best Practice & Research Clinical Gastroenterology 2017; 31(5): 569 doi: 10.1016/j.bpg.2017.09.015
|
| 39 |
Baoqing Zhao, Mengxi Li, Yanting Su, Shigang Shan, Wenbin Qian, Dan Zhu, Xiufen Liu, Zhenwang Zhang. Role of transcription factor FOXM1 in diabetes and its complications (Review). International Journal of Molecular Medicine 2023; 52(5) doi: 10.3892/ijmm.2023.5304
|